This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Biogen Inc (BIIB)

NASDAQ: Health Care

Insider Trading
Historical Data Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago 4 Mo. Ago 5 Mo. Ago 6 Mo. Ago
Net Insider Transaction 20,000 25,508 23,252 4,282 -32,854 102,292 101,262
Shares Bought 20,000 39,358 40,052 22,002 78,692 350,350 348,400
Shares Sold 0 13,850 16,800 17,720 111,546 248,058 247,138
Institutional Trading
Historical Data Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago 4 Mo. Ago 5 Mo. Ago 6 Mo. Ago
Total Shares Held 206.44M 219.53M 219.80M 221.94M 221.94M 221.94M 223.77M
Shares Bought 22.29M 16.57M 14.12M 16.37M 16.37M 16.37M 17.36M
Shares Sold 33.87M 20.10M 19.36M 16.48M 16.48M 16.48M 16.42M

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

Analysts Ratings for BIIB

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 12 12 12 11
Moderate Buy 2 2 2 2
Hold 7 7 8 9
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

BIIB Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs